Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hypertrophic cardiomyopathy: an update

W J McKenna1

  • 1Department of Cardiological Sciences, St George's Hospital Medical School, London, UK.

Cardiologia (Rome, Italy)
|December 1, 1993
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Loss-of-function desmoplakin I and II mutations underlie dominant arrhythmogenic cardiomyopathy with a hair and skin phenotype.

The British journal of dermatology·2018
Same author

Use of high-throughput targeted exome-sequencing to screen for copy number variation in hypertrophic cardiomyopathy.

European journal of medical genetics·2015
Same author

Myocarditis and the military patient.

Journal of the Royal Army Medical Corps·2015
Same author

The natural history of a genetic subtype of arrhythmogenic right ventricular cardiomyopathy caused by a p.S358L mutation in TMEM43.

Clinical genetics·2012
Same author

Cardiomyopathy mutations reveal variable region of myosin converter as major element of cross-bridge compliance.

Biophysical journal·2009
Same author

High-density substrate mapping in Brugada syndrome: combined role of conduction and repolarization heterogeneities in arrhythmogenesis.

Circulation·2009
Same journal

[Prevention in coronary postangioplasty restenosis with omega-3 fatty acids. Results of the Italian study on prevention of restenosis with esapent (ESPRIT)].

Cardiologia (Rome, Italy)·2002
Same journal

[Results of GISSI Prevenzione: diet, drugs, and cardiovascular risk. Researchers of GISSI Prevenzione].

Cardiologia (Rome, Italy)·2002
Same journal

[New therapeutic strategies in heart failure. Which patients need defibrillation backup?].

Cardiologia (Rome, Italy)·2002
Same journal

[Electromechanical re-synchronization with sequential heart stimulation as a new non-pharmacologic treatment of advanced heart failure. Physiopathologic features and clinical results].

Cardiologia (Rome, Italy)·2002
Same journal

[New therapeutic strategies in heart failure. Pharmacologic therapy].

Cardiologia (Rome, Italy)·2002
Same journal

[Genetics as a guide for antihypertensive therapy: future perspectives].

Cardiologia (Rome, Italy)·2002
See all related articles

De novo mutations in the beta cardiac myosin heavy chain gene can cause both familial and sporadic hypertrophic cardiomyopathy (HCM). This finding suggests these forms of HCM are part of a disease spectrum, impacting genetic counseling and risk assessment.

Area of Science:

  • Cardiology
  • Genetics
  • Molecular Biology

Background:

  • Hypertrophic cardiomyopathy (HCM) is an idiopathic heart muscle disorder characterized by ventricular hypertrophy.
  • Histology reveals myocyte disarray and increased connective tissue.
  • Recent advances include gene discovery, mutation identification, and animal models.

Purpose of the Study:

  • To investigate the role of beta cardiac myosin heavy chain gene mutations in sporadic HCM.
  • To determine if de novo mutations cause both familial and sporadic HCM.

Main Methods:

  • Screening of the beta cardiac myosin heavy chain gene in HCM patients.
  • RNase protection assays and other methods for mutation detection.
  • Analysis of mutations in probands and their families.

Related Experiment Videos

Main Results:

  • Seventeen missense mutations in the beta cardiac myosin heavy chain gene were identified exclusively in HCM patients.
  • Two de novo missense mutations (Arg723Cys, Glu924Lys) were found in sporadic HCM probands with unaffected parents.
  • One de novo mutation was germline-transmitted to a daughter.

Conclusions:

  • De novo mutations can cause both familial and sporadic forms of HCM.
  • Sporadic and familial HCM are part of the same disease spectrum.
  • Findings have implications for genetic counseling and risk stratification in HCM management.